Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Dividends

PTSCinvestor -

Cliff merely reitereated what he indicated in his Q&A back on 12/2/11:

"...While PTSC has not ruled out returning cash to its shareholders, no action in this regard is expected to be undertaken until significant uncertainties surrounding the business, litigation, and the licensing program is resolved."

No one at the SHM was privy to any insider info. Period. End of report.

Share
New Message
Please login to post a reply